Beam Therapeutics
Beam Therapeutics is a biotechnology company focused on building a fully integrated platform for precision genetic medicines. The organization utilizes a proprietary suite of gene editing technologies anchored by base editing, which is designed to enable precise single base changes at targeted genomic sequences without making double-stranded breaks in the DNA. This approach supports a diversified portfolio of therapeutic editing programs aimed at addressing serious diseases.
About Beam Therapeutics
Beam Therapeutics is a biotechnology company focused on building a fully integrated platform for precision genetic medicines. The organization utilizes a proprietary suite of gene editing technologies anchored by base editing, which is designed to enable precise single base changes at targeted genomic sequences without making double-stranded breaks in the DNA. This approach supports a diversified portfolio of therapeutic editing programs aimed at addressing serious diseases.
To support its operations, the company maintains enterprise applications and internal systems across business functions such as Operations, Legal, Finance, and Human Resources. The organization integrates technology, data analytics, and artificial intelligence into its business infrastructure, utilizing AI capabilities and automated workflows to optimize administrative processes, improve reporting, and enhance operational effectiveness across enterprise systems.